Manipal Academy of Higher Education (MAHE) in India and Esco Aster in Singapore have signed agreement to establish collaborative research unit at MAHE, Manipal

This is the second Esco Aster collaborative research unit set up globally after the first Centre of Excellence (COE) with Bioprocessing Technology Institute (BTI), Singapore. Esco Aster hopes to continue to develop more collaborations in Asia Pacific in years to come to work on the booming cell and gene therapy.

“As per the agreement, ESCO Aster and MAHE will jointly establish a research unit at MAHE Manipal campus to carry out activities related to development and manufacturing in the biotherapeutics area. MAHE will provide cGMP compliant facility and necessary resources for carrying out the research activities.”

- Lt. General Dr. Venkatesh M.D., MAHE’s Vice Chancellor 

“We are excited to sign this agreement with MAHE and we look forward for harnessing the skilled manpower and mentor pool available at MAHE to build our pipeline products and services to our clients. We envision showcasing this research unit to our potential clients and collaborators and also utilizing it as a training centre.”

-Xiangliang Lin, Esco Aster Chief Executive Officer      

Through this agreement, both parties aim to facilitate research, development, and commercial plans and activities relating to stem cells or extracellular vesicles. Other fields of study with potential advantages to scientific discoveries are also welcome. This collaboration opens up potential breakthrough discoveries aiming to drive the biotherapeutics industry.